aTyr Pharma, Inc.

ATYR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Oct 16, 2026 8-K
SCHEDULE 13G/A Oct 7, 2026
4 Oct 1, 2026 4
3 Oct 1, 2026 3
8-K Sep 24, 2026 8-K
DEF 14A Sep 11, 2026 DEF 14A
PRE 14A Aug 31, 2026 PRE 14A
S-8 Aug 7, 2026 S-8
10-Q Aug 7, 2026 10-Q
8-K Aug 7, 2026 8-K
SCHEDULE 13G/A Aug 6, 2026
8-K Jul 31, 2026 8-K
SCHEDULE 13G/A Jul 27, 2026
SCHEDULE 13G/A Jul 8, 2026
8-K Jun 8, 2026 8-K
SCHEDULE 13G/A Jun 5, 2026
8-K Jun 1, 2026 8-K
4 May 28, 2026 4
10-Q May 15, 2026 10-Q
8-K May 15, 2026 8-K
4 May 13, 2026 4
4 May 13, 2026 4
4 May 13, 2026 4
4 May 13, 2026 4
4 May 13, 2026 4
← Newer Page 1 of 30 · 749 filings Older →